Lucid Diagnostics Inc. (LUCD) Share-based Payment Arrangement, Expense USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lucid Diagnostics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2024.
  • Lucid Diagnostics Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $933 K, a 70.9% decline year-over-year.
  • Lucid Diagnostics Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $4.55 M, a 68.3% decline year-over-year.
  • Lucid Diagnostics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.82 M, a 54.5% decline from 2022.
  • Lucid Diagnostics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15 M, a 56.2% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.55 M $933 K -$2.28 M -70.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $6.82 M $963 K -$2.78 M -74.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $9.6 M $1.25 M -$2.32 M -64.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $11.9 M $1.4 M -$2.45 M -63.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $14.4 M $3.21 M -$627 K -16.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $15 M $3.74 M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $3.57 M +$799 K +28.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $3.84 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $3.84 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $2.77 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.